Casu C, Lo Presti V, Oikonomidou PR, Melchiori L, Abdulmalik O, Ramos P, Rivella S. Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of β-thalassemia intermedia and major. Haematologica 2018; 103(2):e46-e49; https://doi.org/10.3324/haematol.2017.181511.